Compare AUPH & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUPH | ADV |
|---|---|---|
| Founded | 1993 | 1987 |
| Country | Canada | United States |
| Employees | 128 | 69000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 209.6M |
| IPO Year | 2014 | N/A |
| Metric | AUPH | ADV |
|---|---|---|
| Price | $14.22 | $0.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $17.25 | $1.83 |
| AVG Volume (30 Days) | ★ 973.0K | 893.7K |
| Earning Date | 05-11-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $16.53 | $0.63 |
| Revenue Next Year | $16.24 | $0.45 |
| P/E Ratio | $6.75 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $6.83 | $0.49 |
| 52 Week High | $16.54 | $2.11 |
| Indicator | AUPH | ADV |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 59.97 |
| Support Level | $13.52 | $0.80 |
| Resistance Level | $15.23 | $0.97 |
| Average True Range (ATR) | 0.47 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 28.67 | 82.15 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.